Loading...
Therapeutic vaccines in renal cell carcinoma
Metastatic renal cell carcinoma (mRCC) is a lethal disease. The advent of tyrosine kinase inhibitors (TKIs) has changed the disease process, yet the majority of patients will develop treatment-resistant disease. IL-2 based immunotherapy in mRCC is the only US FDA-approved treatment with curative res...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
2011
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3159492/ https://ncbi.nlm.nih.gov/pubmed/21869865 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/thy.11.40 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|